criteria for semaglutide Who Qualifies Semaglutide? Understanding Your Eligibility Key eligibility criteria for STEP

In clinical studies, patients using Semaglutide have seen an average weight loss of 15-18% of their body weight over the course of a year

No specific outcome is guaranteed by any GLP-1 program

By reviewing your medical needs and financial preferences, we help determine the most suitable approach to therapy

How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test examines predispositions in key peptide receptor pathways, including variants in GLP1R (rs6923761), GIPR (rs1800437), and related metabolic genes

This pricing structure means your dose may need adjustment up, but your monthly cost does not change based on dose leveleliminating the financial pressure that sometimes drives patients to skip doses or extend intervals

Ozempic is a once-weekly injectable medication originally developed for type 2 diabetes management